Letter from Lyndal Walker

Letter from Lyndal Walker

Country Manager, Canada for Ipsen Biopharmaceuticals

Welcome to the Ipsen Biopharmaceuticals Canada website.

At Ipsen Biopharmaceuticals, our mission is to develop and deliver innovative therapies to treat serious illnesses and to provide hope for patients, families and health care providers.

Although Ipsen is new to Canada, the company has an 85-year history of developing innovative medical products.  Today, Ipsen’s focus is in three major therapeutic areas: neurology, endocrinology and oncology. Research and development is a major focus for Ipsen Biopharmaceuticals with particular expertise in the areas of peptides and toxins. Our commitment to collaboration with the best in biomedical research internationally strengthens our decades-long commitment to successful best-in-class partnerships with academia, top medical centres and schools, and organizations on the cutting edge of science and medicine.

Ipsen’s decision to launch in Canada in January, 2015 is based on the world-class research and clinical development taking place at leading institutions in Canada and in particular in the GTA.  Today, Canada is a top ten market for the pharmaceutical industry and Ipsen is committed to being a partner in the Canadian healthcare system.  I look forward to building and expanding our relationships with Canadian researchers to advance and expand the treatment options available to patients in our areas of expertise.

Ipsen is a global specialty pharmaceutical company based in Boulogne-Baillancourt in France with major research facilities in Abingdon in the U.K., Cambridge, Massachusetts in the U.S. and in Les Ulis in France.